[LXRX] YoY Annual Result on 31-Dec-2010 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
16-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#FY]
Profit Trend
YoY- -22.95%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 2,222 1,089 1,849 4,908 10,700 32,321 50,118 -40.47%
PBT -104,126 -110,211 -116,215 -101,801 -93,419 -96,884 -71,233 6.52%
Tax -833 -1,971 -2,359 -26 -102 -19,675 -16,160 -38.96%
NP -104,126 -110,211 -116,215 -101,775 -82,780 -76,860 -58,794 9.98%
Tax Rate - - - - - - - -
Total Cost 106,348 111,300 118,064 106,683 93,480 109,181 108,912 -0.39%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin -4,686.14 -10,120.39 -6,285.29 -2,073.66 -773.64 -237.80 -117.31 84.78%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS -1.42 -1.58 -2.39 -2.35 -3.98 -3.93 -4.12 -16.25%
EPS Diluted -1.42 -1.58 -2.39 -2.35 -3.98 -3.93 -4.12 -16.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.